We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+9.13%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.4B
AUM Growth
+$4.2B
(+18%)
Cap. Flow
+$2.08B
Cap. Flow
% of AUM
7.6%
Top 10 Holdings %
Top 10 Hldgs %
54.51%
Holding
1,686
New
164
Increased
291
Reduced
361
Closed
70
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$1.87B |
| 2 |
VMEO
Vimeo
VMEO
|
+$223M |
| 3 |
Amazon
AMZN
|
+$167M |
| 4 |
Meta Platforms (Facebook)
META
|
+$118M |
| 5 |
ZTO Express
ZTO
|
+$42.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$187M |
| 2 |
Alibaba
BABA
|
+$55.4M |
| 3 |
TVRD
Tvardi Therapeutics
TVRD
|
+$47.1M |
| 4 |
Charter Communications
CHTR
|
+$31.9M |
| 5 |
STAY
Extended Stay America, Inc. Paired Share Unit
STAY
|
+$28.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 41.9% |
| 2 | Technology | 15.81% |
| 3 | Healthcare | 10.24% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Communication Services | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
iShares MSCI China ETF
MCHI
$6.04B
| $370K | ﹤0.01% |
4,500
| – | – |
|
602
iShares Russell 1000 Growth ETF
IWF
$122B
| $369K | ﹤0.01% |
5,440
| – | – |
|
603
Biogen
BIIB
$29.9B
| $367K | ﹤0.01% |
1,060
+940
| +783% | +$285K |
|
604
Cerus
CERS
$587M
| $366K | ﹤0.01% |
62,000
| – | – |
|
605
Expedia Group
EXPE
$31.2B
| $365K | ﹤0.01% |
2,232
| – | – |
|
606
TD Synnex
SNX
$19.4B
| $365K | ﹤0.01% |
3,000
| – | – |
|
607
MarketAxess Holdings
MKTX
$4.15B
| $363K | ﹤0.01% |
785
| – | – |
|
608
Invesco Golden Dragon China ETF
PGJ
$92.8M
| $362K | ﹤0.01% |
5,916
| – | – |
|
609
Zoom
ZM
$25.8B
| $361K | ﹤0.01% |
934
| – | – |
|
610
Eastman Chemical
EMN
$7.8B
| $359K | ﹤0.01% |
3,080
+158
| +5% | +$19K |
|
611
Five Point Holdings
FPH
$379M
| $359K | ﹤0.01% |
44,500
-24,000
| -35% | -$182K |
|
612
State Street
STT
$50.9B
| $359K | ﹤0.01% |
4,371
-58
| -1% | -$4.9K |
|
613
Elevance Health
ELV
$81.9B
| $353K | ﹤0.01% |
926
+150
| +19% | +$57.3K |
|
614
VanEck India Growth Leaders ETF
GLIN
$93.7M
| $353K | ﹤0.01% |
9,125
| – | – |
|
615
Vertex Pharmaceuticals
VRTX
$121B
| $352K | ﹤0.01% |
1,750
-400
| -19% | -$83.7K |
|
616
WD-40
WDFC
$3.1B
| $351K | ﹤0.01% |
1,370
+20
| +1% | +$5.11K |
|
617
TransDigm Group
TDG
$69.2B
| $343K | ﹤0.01% |
530
-40
| -7% | -$25.1K |
|
|
LBAI
618
DELISTED
Lakeland Bancorp Inc
LBAI
| $342K | ﹤0.01% |
19,600
| – | – |
|
|
PBCT
619
DELISTED
People's United Financial Inc
PBCT
| $342K | ﹤0.01% |
19,994
| – | – |
|
|
XOMA
620
DELISTED
Xoma
XOMA
| $340K | ﹤0.01% |
10,000
| – | – |
|
621
Freeport-McMoran
FCX
$90B
| $338K | ﹤0.01% |
9,135
| – | – |
|
622
L3Harris
LHX
$55.9B
| $338K | ﹤0.01% |
1,568
-25
| -2% | -$5.38K |
|
|
SVM
623
Silvercorp Metals
SVM
$2.13B
| $337K | ﹤0.01% |
61,400
| – | – |
|
624
First Horizon
FHN
$12.1B
| $336K | ﹤0.01% |
19,475
-2,505
| -11% | -$45.5K |
|
|
HBI
625
DELISTED
Hanesbrands
HBI
| $335K | ﹤0.01% |
17,982
+150
| +0.8% | +$2.97K |
|
Similar funds
SAM
First Manhattan's Q2 2021 Portfolio in Review
As of Q2 2021, First Manhattan held 1,686 positions worth $27.4B, up 18% from $23.2B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
First Manhattan deployed $2.08B of net new capital in Q2 2021, opening 164 new positions and adding to 291 existing holdings. Its largest new stake was Vimeo: 4,840,524 shares worth $237M.
By sector, the portfolio is most concentrated in Financials at 42% of assets, up from 38% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was People Inc, an estimated $187M trimmed.
- First Manhattan's largest Q2 2021 buy was Vimeo: 4,840,524 shares worth $237M.
- First Manhattan added most to Berkshire Hathaway Class A in Q2 2021, an estimated $1.87B increase.
- First Manhattan's biggest Q2 2021 reduction was People Inc, cutting an estimated $187M.
- First Manhattan fully exited Tvardi Therapeutics in Q2 2021, selling an estimated $47.1M.
- First Manhattan's ten largest holdings make up 55% of its $27.4B portfolio in Q2 2021.
- First Manhattan opened 164 new positions and closed 70 in Q2 2021.
- First Manhattan's portfolio value rose 18% quarter-over-quarter to $27.4B.
Based on First Manhattan's 13F filing for Q2 2021, filed 16 Aug 2021.